Skip to main content

Table 3 Associations between bacterial vaginosis and adverse outcomes among full-term infants (37 weeks or greater gestation), Washington State, 2003-2013 (N = 11,354), adjusted for gestational age, maternal age, and maternal race, and additionally adjusted for the presence of chorioamnionitis or meconium

From: Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study

  BV exposed BV unexposed aRR 95 % CI
N = 2198 N = 9156
n % n %   
Assisted ventilation at birth 98 4.5 328 3.6 1.28 1.02–1.61
 additionally adjusted for chorioamnionitis 98 4.5 328 3.6 1.28 1.02–1.61
 additionally adjusted for meconium 98 4.5 328 3.7 1.22 0.97–1.53
Admission to NICU at birth 88 4.1 269 3.0 1.42 1.11–1.82
 additionally adjusted for chorioamnionitis 88 4.1 269 3.0 1.45 1.13–1.85
 additionally adjusted for meconium 88 4.1 267 3.0 1.34 1.05–1.72
Neonatal sepsis 48 2.2 125 1.4 1.60 1.13–2.27
 additionally adjusted for chorioamnionitis 48 2.2 125 1.4 1.67 1.19–2.35
 additionally adjusted for meconium 48 2.2 125 1.4 1.51 1.06–2.14
Fetal Mortality 3 0.1 12 0.1 1.15* 0.27–4.96
 additionally adjusted for chorioamnionitis 3 0.1 12 0.1 1.14* 0.27–4.88
 additionally adjusted for meconium 0 0.0 3 0.0 - -
Infant mortality 3 0.1 24 0.3 0.39 0.12–1.28
 additionally adjusted for chorioamnionitis 3 0.1 24 0.3 0.39 0.12–1.27
 additionally adjusted for meconium 3 0.1 23 0.3 0.40 0.12–1.34
  1. BV bacterial vaginosis, aRR adjusted risk ratio, CI confidence interval, NICU neonatal intensive care unit
  2. *further adjusted for presence of sexually transmitted infections (syphilis, gonorrhea, chlamydia, and/or genital herpes)